Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice

被引：19
作者：
Litten, Raye Z. [1 ]
Falk, Daniel E. [1 ]
Ryan, Megan L. [1 ]
Fertig, Joanne [1 ]
Leggio, Lorenzo [2 ,3 ,4 ]
机构：
[1] NIAAA, Bethesda, MD USA
[2] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, NIH, Bethesda, MD USA
[3] NIDA, Medicat Dev Program, NIH, Baltimore, MD USA
[4] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2020年 / 44卷 / 01期
关键词：
Medications; Alcohol Use Disorder; Personalized Medicine; Targets; Screening Models; Medication Use; Health Services; Dissemination; PLACEBO-CONTROLLED TRIAL; ADDICTIONS NEUROCLINICAL ASSESSMENT; CELL-BASED MODELS; DOUBLE-BLIND; NALTREXONE RESPONSE; PRIMARY-CARE; DEPENDENT INDIVIDUALS; EXPRESSION SIGNATURES; RECEPTOR ANTAGONIST; PRECISION MEDICINE;
D O I：
10.1111/acer.14233
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：23 / 35
页数：13
相关论文
共 50 条
  • [31] Thiamin and alcohol use disorder: A national survey of practice
    Collet, Laura
    Bisch, Michael
    Viennet, Sarah
    Schwan, Raymund
    Paille, Francois
    THERAPIE, 2020, 75 (03): : 281 - 294
  • [32] A novel human laboratory model for screening medications for alcohol use disorder
    Diana Ho
    Brandon Towns
    Erica N. Grodin
    Lara A. Ray
    Trials, 21
  • [33] Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models
    Yardley, Megan M.
    Ray, Lara A.
    ADDICTION BIOLOGY, 2017, 22 (03) : 581 - 615
  • [34] New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
    Morley, Kirsten C.
    Perry, Christina J.
    Watt, Joshua
    Hurzeler, Tristan
    Leggio, Lorenzo
    Lawrence, Andrew J.
    Haber, Paul
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1291 - 1303
  • [35] Association Between Gabapentin Receipt for Any Indication and Alcohol Use Disorders Identification TestConsumption Scores Among Clinical Subpopulations With and Without Alcohol Use Disorder
    Rentsch, Christopher T.
    Fiellin, David A.
    Bryant, Kendall J.
    Justice, Amy C.
    Tate, Janet P.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (03) : 522 - 530
  • [36] Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making
    Bhardwaj, Anvita
    Sousa, Jessica L.
    Huskamp, Haiden A.
    Busch, Alisa B.
    Kennedy-Hendricks, Alene
    Hodgkin, Dominic
    Horgan, Constance
    Uscher-Pines, Lori
    ANNALS OF FAMILY MEDICINE, 2023, 21 (04) : 332 - 337
  • [37] Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research
    Czoty, Paul W.
    Stoops, William W.
    Rush, Craig R.
    PHARMACOLOGICAL REVIEWS, 2016, 68 (03) : 533 - 562
  • [38] Integrated treatment of depression and moderate to severe alcohol use disorder in women shows promise in routine alcohol use disorder care - a pilot study
    Persson, Anna
    Finn, Daniel Wallhed
    Broberg, Alice
    Westerberg, Amanda
    Magnusson, Asa
    Molander, Olof
    FRONTIERS IN PSYCHIATRY, 2025, 16
  • [39] Burden of alcohol use and inclusion of alcohol use disorder medications in the essential medicine lists across 132 countries: An observational study
    Parmar, Arpit
    Sahu, Dinesh Prasad
    Behera, Priyamadhaba
    ALCOHOL, 2025, 122 : 111 - 114
  • [40] First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers
    Gregory, Caroline
    Chorny, Yelena
    McLeod, Shelley L.
    Mohindra, Rohit
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (04) : E210 - E218
12345